Clin Colon Rectal Surg 2019; 32(01): 069-074
DOI: 10.1055/s-0038-1673356
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Review of Colorectal Studies Using the National Cancer Database

Katherine A. Kelley
1   Division of Gastrointestinal and General Surgery, Department of General Surgery, Oregon Health and Science University Portland, Portland, OR
V. Liana Tsikitis
1   Division of Gastrointestinal and General Surgery, Department of General Surgery, Oregon Health and Science University Portland, Portland, OR
› Author Affiliations
Further Information

Publication History

Publication Date:
08 January 2019 (online)


The National Cancer Database (NCDB) is a large clinical oncology database developed with data collected from Commission on Cancer (CoC)-accredited facilities. The CoC is managed under the American College of Surgeons, and is a multidisciplinary team that maintains standards in cancer care delivery in health care settings. This database has been used in multiple cancer-focused studies and reports on cancer diagnosis, hospital-level, and patient-related demographics. The focus of this review is to explore and discuss the use of NCDB in colorectal surgery research. Furthermore, our aim for this review is to formulate a guide for researchers who are interested in using the NCDB to complete colorectal research.

  • References

  • 1 American College of Surgeons. National Cancer Database. 2016; Available at: . Accessed August 30, 2016
  • 2 Newman LA, Lee CT, Parekh LP. , et al; American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer 2006; 106 (01) 188-195
  • 3 DeSantis CE, Lin CC, Mariotto AB. , et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64 (04) 252-271
  • 4 Siegel R, DeSantis C, Virgo K. , et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62 (04) 220-241
  • 5 Bilimoria KY, Palis B, Stewart AK. , et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum 2008; 51 (02) 154-161
  • 6 Bilimoria KY, Stewart AK, Palis BE, Bentrem DJ, Talamonti MS, Ko CY. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg 2008; 206 (02) 247-254
  • 7 Hyngstrom JR, Hu CY, Xing Y. , et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 2012; 19 (09) 2814-2821
  • 8 Hsu C, Rashid A, Xing Y. , et al. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol 2013; 107 (02) 136-143
  • 9 Chagpar R, Chiang YJ, Xing Y. , et al. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol 2013; 20 (04) 1170-1178
  • 10 You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention?. Arch Intern Med 2012; 172 (03) 287-289
  • 11 Poles GC, Clark DE, Mayo SW. , et al. Colorectal carcinoma in pediatric patients: a comparison with adult tumors, treatment and outcomes from the National Cancer Database. J Pediatr Surg 2016; 51 (07) 1061-1066
  • 12 Esnaola NF, Stewart AK, Feig BW, Skibber JM, Rodriguez-Bigas MA. Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base. Ann Surg Oncol 2008; 15 (11) 3036-3047
  • 13 Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 2008; 9 (03) 222-231
  • 14 Robbins AS, Chen AY, Stewart AK, Staley CA, Virgo KS, Ward EM. Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base. Cancer 2010; 116 (17) 4178-4186
  • 15 Ward EM, Fedewa SA, Cokkinides V, Virgo K. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J 2010; 16 (06) 614-621
  • 16 Halpern MT, Pavluck AL, Ko CY, Ward EM. Factors associated with colon cancer stage at diagnosis. Dig Dis Sci 2009; 54 (12) 2680-2693
  • 17 Robbins AS, Pavluck AL, Fedewa SA, Chen AY, Ward EM. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol 2009; 27 (22) 3627-3633
  • 18 Stitzenberg KB, Sanoff HK, Penn DC, Meyers MO, Tepper JE. Practice patterns and long-term survival for early-stage rectal cancer. J Clin Oncol 2013; 31 (34) 4276-4282
  • 19 You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg 2007; 245 (05) 726-733
  • 20 Nussbaum DP, Speicher PJ, Ganapathi AM. , et al. Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base. J Gastrointest Surg 2015; 19 (01) 124-131 , discussion 131–132
  • 21 Rickles AS, Dietz DW, Chang GJ. , et al; Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh). High rate of positive circumferential resection margins following rectal cancer surgery: a call to action. Ann Surg 2015; 262 (06) 891-898
  • 22 Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ. National disparities in minimally invasive surgery for rectal cancer. Surg Endosc 2016; 30 (03) 1060-1067
  • 23 Gulack BC, Nussbaum DP, Keenan JE. , et al. Surgical resection of the primary tumor in stage IV colorectal cancer without metastasectomy is associated with improved overall survival compared with chemotherapy/radiation therapy alone. Dis Colon Rectum 2016; 59 (04) 299-305
  • 24 Shih YC, Elting LS, Halpern MT. Factors associated with immunotherapy use among newly diagnosed cancer patients. Med Care 2009; 47 (09) 948-958
  • 25 Ganapathi AM, Speicher PJ, Englum BR. , et al. Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit. Dis Colon Rectum 2014; 57 (12) 1341-1348
  • 26 Probst CP, Becerra AZ, Aquina CT. , et al; Consortium for Optimizing the Surgical Treatment of Rectal Cancer (OSTRiCh). Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation. J Am Coll Surg 2015; 221 (02) 430-440
  • 27 Krell RW, Regenbogen SE, Wong SL. Variation in hospital treatment patterns for metastatic colorectal cancer. Cancer 2015; 121 (11) 1755-1761
  • 28 Boland GM, Chang GJ, Haynes AB. , et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 2013; 119 (08) 1593-1601
  • 29 van Roessel P, Rouse RV, Wren SM. Care within a Veterans hospital: earlier detection of colon cancer. Surg Endosc 2007; 21 (08) 1434-1440
  • 30 Mallin K, Palis BE, Watroba N. , et al. Completeness of American Cancer Registry Treatment Data: implications for quality of care research. J Am Coll Surg 2013; 216 (03) 428-437
  • 31 Shi Q, You YN, Nelson H. , et al. Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study. Clin Trials 2010; 7 (06) 686-695
  • 32 Merkow RP, Kmiecik TE, Bentrem DJ. , et al. Effect of including cancer-specific variables on models examining short-term outcomes. Cancer 2013; 119 (07) 1412-1419